相关实验视频

Updated: May 6, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

全免疫-炎症值预测炎症性乳腺癌患者的生存率

Yingjia Hu¹, Jian Li¹, Mingyu Wang²

¹Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China.

Experimental biology and medicine (Maywood, N.J.)

|May 16, 2025

概括

全免疫-炎症值 (PIV) 是一种新的生物标志物,它显示了炎症性乳腺癌 (IBC) 患者生存结果的显著预测价值. 在IBC患者中观察到更高的PIV水平,表明其作为预后指标的潜力.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物标志物研究生物标志物研究

背景情况:

炎症性乳腺癌 (IBC) 是一种罕见的,具有不良预后的侵袭性亚型.
新的生物标志物对于预测IBC患者的存活率至关重要.
现有的外周血液参数缺乏全面的预后价值.

研究的目的:

调查泛免疫炎症值 (PIV) 在炎症性乳腺癌 (IBC) 的预后价值.
为了比较IBC和非IBC队列之间的PIV水平.
在IBC中探索PIV和临床特征之间的关系.

主要方法:

对143名IBC患者的回顾性分析.
使用外周血液参数 (淋巴细胞,单细胞,中性细胞,血小板) 计算PIV.
单变量和多变量统计分析用于DFS和OS的预后评估.

主要成果:

与IBC中的其他外周血液参数相比,PIV显示出更高的预测值.
IBC患者的PIV平均值明显高于非IBC患者.
在IBC中,PIV被确定为无病生存期 (DFS) 和总生存期 (OS) 的独立预后指标.

结论:

PIV是炎症性乳腺癌 (IBC) 的一个有价值的预后生物标志物.
PIV可以帮助预测治疗结果和了解IBC进展.
进一步研究PIV在IBC病原发生中的作用是有必要的.

关键词:

生物标志物生物标志物免疫系统是免疫系统的.炎症性乳腺癌是一种炎症性乳腺癌.全免疫性炎症的价值.预后预后预后

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...